Advisory

Swap, don’t sell: Driving value through asset swaps

The Swiss Pharmaceuticals sector produced four USD1 billion+ deals in the first half of 2018. This is not surprising given the efforts by Pharmaceuticals and Life Sciences businesses to push new boundaries and continuously innovate.

Combating money laundering: Switzerland shifts to a higher gear

The Swiss Federal Council has ratified the FDF’s draft of the Anti-Money Laundering Act (AMLA) in June 2018 and issued the corresponding draft for consultation until 21 September 2018. The planned amendments to the AMLA address the weaknesses identified by the Financial Action Task Force.

Donor fraud is on the rise. How can you protect your organization?

Donor fraud is on the rise, but today’s charitable and nonprofit organizations aren’t doing enough to protect themselves. Tracking how and where the donations are spent is just the tip of the iceberg. Monitoring who the donor is and where the money comes from – is equally important.

How much do you value your favorite football star?

The FIFA Football World Cup is over for another four years. In some teams, a new generation of players made their mark. In others, the old guard stood firm. For both, performances on the world stage may fuel transfers between clubs, with huge amounts of money at stake. But how are players’ values determined?
4 1

GDPR gives Data Protection Officers a hard time: How can they tackle it?

It’s sink or swim for DPOs as the GDPR creates a tsunami of challenges. With the stakes high, DPOs face great personal risk if they get it wrong. Still, they lack the resources, in-house know-how and authority to pull together the necessary expertise to deal with the rising tide of urgent requests.

First M&A half-year: Numerous IPOs and substantial private equity activity

M&A activity in Switzerland remains at a high level. The M&A year to date has been characterized by larger deals in the pharmaceutical and consumer goods industries, a number of IPOs and an ongoing high level of activity among private equity investors.